BackAnixa Biosciences Overview

Anixa Biosciences Accounts Payable

Track Anixa Biosciences's accounts payable ($250K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$252000.00
↓ 11.27% YoYΔ $-32000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Anixa Biosciences Accounts Payable History

Loading

Anixa Biosciences vs. peers: Accounts Payable Comparison

Loading

Anixa Biosciences Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Anixa Biosciences (ANIX) FAQ

As of the most recent data (April 2026), ANIX shows a accounts payable of $250K. That compares with $280K in the prior-year period — down 11.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ANIX's accounts payable is now $250K (was $280K) — a 11.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Anixa Biosciences is outperforming or lagging.

Tracking ANIX's accounts payable over time shows whether Anixa Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $250K That compares with $280K in the prior-year period — down 11.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Anixa Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $250K) with ownership activity and broader fundamentals.

Anixa Biosciences's accounts payable is $250K; compare it with other Technology names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.